ABSTRACT
Chitosan is a widely employed polysaccharide with positive zeta-potential and better tissue/cell adhesion. Its hydrophilicity, high viscosity, and insolubility at physiological pH are major hurdles in proper utilization of this macromolecule. Therefore, it was conjugated with biocompatible stearic acid and the conjugate was employed to develop polymeric micelles for delivery of tamoxifen to breast cancer cells. The conjugate was characterized by FT-IR and NMR, and the nanocarrier was characterized for micromeritics, surface charge, drug loading, and morphological attributes. The efficacy was evaluated by in vitro MTT studies, safety by erythrocyte compatibility, and biodistribution by in vivo pharmacokinetic studies. Despite better drug loading and sustained drug release, cytotoxicity on MCF-7 breast cancer cells was substantially enhanced and the pharmacokinetic profile was significantly modified. The AUC was enhanced manifolds along with reduced clearance. The findings are unique and provide an alternative to the conventional lipid-based nanocarriers for better dose delivery, tissue adhesion, and desired pharmacokinetic modulation.
Similar content being viewed by others
References
Sahana B, Santra K, Basu S, Mukherjee B. Development of biodegradable polymer based tamoxifen citrate loaded nanoparticles and effect of some manufacturing process parameters on them: a physicochemical and in-vitro evaluation. Int J Nanomedicine. 2010;5:621–30.
Jordan VC. Tamoxifen: a most unlikely pioneering medicine. Nat Rev Drug Discov. 2003;2(3):205–13.
Memisoglu-Bilensoy E, Vural I, Bochot A, Renoir JM, Duchene D, Hincal AA. Tamoxifen citrate loaded amphiphilic beta-cyclodextrin nanoparticles: in vitro characterization and cytotoxicity. J Control Release. 2005;104(3):489–96.
Dickschen K, Willmann S, Thelen K, Lippert J, Hempel G, Eissing T. Physiologically based pharmacokinetic modeling of tamoxifen and its metabolites in women of different CYP2D6 phenotypes provides new insight into the tamoxifen mass balance. Front Pharmacol Front. 2012;3.
Bhatia A, Singh B, Raza K, Wadhwa S, Katare OP. Tamoxifen-loaded lecithin organogel (LO) for topical application: development, optimization and characterization. Int J Pharm. 2013;444(1–2):47–59.
Bhatia A, Kumar R, Katare OP. Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation. J Pharm Pharm Sci Publ Can Soc Pharm Sci So Can Sci Pharm. 2004;7(2):252–9.
Cavallaro G, Maniscalco L, Licciardi M, Giammona G. Tamoxifen-loaded polymeric micelles: preparation, physico-chemical characterization and in vitro evaluation studies. Macromol Biosci. 2004;4(11):1028–38.
Altmeyer C, Karam TK, Khalil NM, Mainardes RM. Tamoxifen-loaded poly(L-lactide) nanoparticles: development, characterization and in vitro evaluation of cytotoxicity. Mater Sci Eng C. 2016;60:135–42.
Hu F-Q, Wu X-L, Du Y-Z, You J, Yuan H. Cellular uptake and cytotoxicity of shell crosslinked stearic acid-grafted chitosan oligosaccharide micelles encapsulating doxorubicin. Eur J Pharm Biopharm Off J Arbeitsgemeinschaft Pharm Verfahrenstechnik. 2008;69(1):117–25.
Prabaharan M. Chitosan-based nanoparticles for tumor-targeted drug delivery. Int J Biol Macromol. 2015;72:1313–22.
Sipoli CC, Radaic A, Santana N, de Jesus MB, de la Torre LG. Chitosan nanoparticles produced with the gradual temperature decrease technique for sustained gene delivery. Biochem Eng J. 2015;103:114–21.
Hu F-Q, Ren G-F, Yuan H, Du Y-Z, Zeng S. Shell cross-linked stearic acid grafted chitosan oligosaccharide self-aggregated micelles for controlled release of paclitaxel. Colloids Surf B Biointerfaces. 2006;50(2):97–103.
Hu P, Wang T, Xu Q, Chang Y, Tu H, Zheng Y, et al. Genotoxicity evaluation of stearic acid grafted chitosan oligosaccharide nanomicelles. Mutat Res. 2013;751(2):116–26.
Xie Y-T, Du Y-Z, Yuan H, Hu F-Q. Brain-targeting study of stearic acid-grafted chitosan micelle drug-delivery system. Int J Nanomedicine. 2012;7:3235–44.
Huang M, Ma Z, Khor E, Lim L-Y. Uptake of FITC-chitosan nanoparticles by A549 cells. Pharm Res. 2002;19(10):1488–94.
Du Y-Z, Lu P, Zhou J-P, Yuan H, Hu F-Q. Stearic acid grafted chitosan oligosaccharide micelle as a promising vector for gene delivery system: factors affecting the complexation. Int J Pharm. 2010;391(1–2):260–6.
Raza K, Singh B, Singla N, Negi P, Singal P, Katare OP. Nano-lipoidal carriers of isotretinoin with anti-aging potential: formulation, characterization and biochemical evaluation. J Drug Target. 2013;21(5):435–42.
Reddy LH, Vivek K, Bakshi N, Murthy RSR. Tamoxifen citrate loaded solid lipid nanoparticles (SLN™): preparation, characterization, in vitro drug release, and pharmacokinetic evaluation. Pharm Dev Technol. Taylor & Francis; 2008.
Raza K, Thotakura N, Kumar P, Joshi M, Bhushan S, Bhatia A, et al. C60-fullerenes for delivery of docetaxel to breast cancer cells: a promising approach for enhanced efficacy and better pharmacokinetic profile. Int J Pharm. 2015;495(1):551–9.
Rizvi MA, Guru S, Naqvi T, Kumar M, Kumbhar N, Akhoon S, et al. An investigation of in vitro cytotoxicity and apoptotic potential of aromatic diselenides. Bioorg Med Chem Lett. 2014;24(15):3440–6.
Jain AK, Thanki K, Jain S. Co-encapsulation of tamoxifen and quercetin in polymeric nanoparticles: implications on oral bioavailability, antitumor efficacy, and drug-induced toxicity. Mol Pharm Am Chem Soc. 2013;10(9):3459–74.
Shargel L, Wu-Pong S, Yu A. Applied biopharmaceutics and pharmacokinetics, 5th edition. Ann Intern Med. 2004. p. 826.
Gaumet M, Vargas A, Gurny R, Delie F. Nanoparticles for drug delivery: the need for precision in reporting particle size parameters. Eur J Pharm Biopharm. 2008;69(1):1–9.
Hu Y, Jiang X, Ding Y, Ge H, Yuan Y, Yang C. Synthesis and characterization of chitosan–poly(acrylic acid) nanoparticles. Biomaterials. 2002;23(15):3193–201.
Sharma G, Dhankar G, Thakur K, Raza K, Katare OP. Benzyl benzoate-loaded microemulsion for topical applications: enhanced dermatokinetic profile and better delivery promises. AAPS PharmSciTech. 2015.
Jeswani G, Alexander A, Saraf S, Saraf S, Qureshi A, Ajazuddin. Recent approaches for reducing hemolytic activity of chemotherapeutic agents. J Control Release. 2015;211:10–21.
Hutson PR, Love RR, Havighurst TC, Rogers E, Cleary JF. Effect of exemestane on tamoxifen pharmacokinetics in postmenopausal women treated for breast cancer. Clin Cancer Res. 2005;11(24 Pt 1):8722–7.
ACKNOWLEDGMENTS
The authors acknowledge the financial support from the University Grants Commission, New Delhi, India, in the form of UGC-Start-Up Grant to the corresponding author.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors report that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Thotakura, N., Dadarwal, M., Kumar, P. et al. Chitosan-Stearic Acid Based Polymeric Micelles for the Effective Delivery of Tamoxifen: Cytotoxic and Pharmacokinetic Evaluation. AAPS PharmSciTech 18, 759–768 (2017). https://doi.org/10.1208/s12249-016-0563-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1208/s12249-016-0563-6